Julie A. Cabading

Julie Cabading practices at Gustavo a Mondragon MD a Medical Corporation in Chula Vista, California.

Julie Cabading's NPI, 1346944287, was assigned on March 27, 2023. Julie Cabading holds California license 95024672.

Julie Cabading's primary practice is Gustavo a Mondragon MD a Medical Corporation, at 480 4th Ave, Chula Vista, CA 91910 in San Diego County. The practice phone is (619) 656-5252.

Julie Cabading's primary practice is Gustavo a Mondragon MD a Medical Corporation in Chula Vista, California. The medical group on file is KMG Psychiatry. Dmand AI also links Julie Cabading to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Julie Cabading practices. Vendor and product names are available with a free account.

Psychiatric/mental health is Julie Cabading's primary specialty in the NPI Registry, under taxonomy code 363LP0808X. Julie Cabading is licensed in California.

CMS data shows 242 Medicare services from Julie Cabading across 3 procedure codes in 2024, for 36 Medicare patients. Medicare paid $18,371 for them. Every service was in an office.

CMS counts 36 Medicare patients who saw Julie Cabading in 2024. The largest group is under 65, with 14 patients. 75% of them have anxiety, and 75% have mood disorders. 44% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Julie Cabading's median patient age at 58, with 53% women.

In 2024, Julie Cabading wrote 1,020 Medicare Part D claims for 77 patients. 93% of them were for generic drugs. CMS names the drug for 903 of them, across 26 drugs with 11 or more claims each, at $256,600 in total drug cost.

Julie Cabading accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Julie Cabading as offering telehealth.

CMS Open Payments shows 2 general payments to Julie Cabading from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $27.